UBS Oconnor LLC
- SEC CIK
- 0001132716
- Latest filing
- Aug 14, 2026
HZNP holding history
Horizon Therapeutics Public Ltd Co in every 13F filed by UBS Oconnor LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HZNP overviewAll 13F holders of HZNPFull Q4 2025 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −7,664,245−100.0% | Sold out | Holders |
| Q3 2023 | 7,664,245 | $886.7M | 15.9% | +3,332,978+77.0% | Added | Holders |
| Q2 2023 | 4,331,267 | $445.5M | 9.4% | +338,535+8.5% | Added | Holders |
| Q1 2023 | 3,992,732 | $434.5M | 10.4% | +1,706,942+74.7% | Added | Holders |
| Q4 2022 | 2,285,790 | $260.1M | 12.8% | +2,211,443+2,974.5% | Added | Holders |
| Q3 2022 | 74,347 | $4.60M | 0.1% | −5,000−6.3% | Reduced | Holders |
| Q2 2022 | 79,347 | $6.33M | 0.1% | +79,347 | New | Holders |